Search
for
Sort by
Research 151–180 of 551
- Pattern of Skin disorders across age groups
- The skin findings of pregnant women and our treatment choices. A Turkish experience: a 5-year survey.
- Clinical Management in Psychodermatology
- Cutaneous manifestations of systemic infection in children
- Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature
- Therapeutic options in the polycystic ovary syndrome
- Polycystic Ovary Syndrome: Management of a Long-Term Condition in Primary Care
- INDIVIDUALIZED TREATMENT OF POLYCYSTIC OVARY SYNDROME: A MANIFESTATION-GUIDED PRACTICAL APPROACH
- Genetic, hormonal and metabolic aspects of PCOS: an update
- Polycystic Ovary Syndrome
- Dermatoses of pregnancy
- An Update of Congenital Adrenal Hyperplasia
- Current evaluation of amenorrhea
- Frontal Fibrosing Alopecia: An Update on Pathogenesis, Diagnosis, and Treatment
- Normal Hair Growth in Children
- Current evaluation of amenorrhea
- The bright side of fibroblasts: molecular signature and regenerative cues in major organs
- Gender-Affirming Hormone Therapy for Transgender Females
- Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young women
- Skin disease in pregnancy
- Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology
- Venous thromboembolism and women's health
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- Secondary cicatricial and other permanent alopecias
- Current aspects of polycystic ovary syndrome: A literature review
- Targets to treat androgen excess in polycystic ovary syndrome
- Collagen-Heparin-FGF2-VEGF Scaffolds Induce a Regenerative Gene Expression Profile in a Fetal Sheep Wound Model
- Women’s Health Considerations for Lipid Management
- Variable expressivity of syndromic BMP4-related eye, brain, and digital anomalies: A review of the literature and description of three new cases
- The Charnoly body as a universal biomarker of cell injury